KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $61.3 billion.

  • Bristol Myers Squibb's Non-Current Assets fell 661.03% to $61.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $247.2 billion, marking a year-over-year decrease of 745.86%. This contributed to the annual value of $62.8 billion for FY2024, which is 89.29% down from last year.
  • As of Q3 2025, Bristol Myers Squibb's Non-Current Assets stood at $61.3 billion, which was down 661.03% from $61.5 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Non-Current Assets peaked at $85.3 billion during Q1 2021, and registered a low of $61.3 billion during Q3 2025.
  • For the 5-year period, Bristol Myers Squibb's Non-Current Assets averaged around $69.3 billion, with its median value being $67.8 billion (2024).
  • In the last 5 years, Bristol Myers Squibb's Non-Current Assets crashed by 1454.57% in 2022 and then skyrocketed by 471.31% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Non-Current Assets (Quarter) stood at $76.1 billion in 2021, then dropped by 8.55% to $69.5 billion in 2022, then decreased by 8.85% to $63.4 billion in 2023, then decreased by 0.89% to $62.8 billion in 2024, then fell by 2.49% to $61.3 billion in 2025.
  • Its Non-Current Assets stands at $61.3 billion for Q3 2025, versus $61.5 billion for Q2 2025 and $61.6 billion for Q1 2025.